← Back to list
Newsletter Vol. 9, No. 01
Act
immediately
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
New monitoring system implemented for therapeutic duplication (PDUR) to identify when patients receive multiple similar medications that could cause harmful interactions or redundant therapy. This affects prescription-related billing and may impact prior authorization requirements for duplicate therapeutic classes.
Get alerts when payers change rules like this one
We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.
Get New Jersey Medicaid alertsPolicy Monitoring is free. No card required.
What to do
immediately · 2 steps
01Review current prescription billing practices to ensure awareness of new therapeutic duplication monitoring.
02Coordinate with providers to verify all prescription-related claims align with PDUR guidelines to avoid potential claim reviews or denials for duplicate therapies.
Original notice
Newsletter Vol. 9, No. 01
njmmis.com · Always check the source before changing claims.
Related changes
See all New Jersey Medicaid changes →Newsletter Vol. 9, No. 07LowEffective Jan 1, 1999 · Provider NoticeNewsletter Vol. 9, No. 08MediumEffective Jan 1, 1999 · Provider NoticeNewsletter Vol. 9, No. 02HighEffective Jan 1, 1999 · Prior AuthorizationNewsletter Vol. 9, No. 04MediumNo effective date · CodingBrowse every New Jersey Medicaid change in the policy list